RISSO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 345
EU - Europa 113
AS - Asia 99
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 561
Nazione #
US - Stati Uniti d'America 336
IT - Italia 52
CN - Cina 45
SG - Singapore 27
IE - Irlanda 17
FI - Finlandia 13
CA - Canada 9
SE - Svezia 8
VN - Vietnam 8
ID - Indonesia 6
LU - Lussemburgo 6
FR - Francia 5
KR - Corea 5
BE - Belgio 3
TW - Taiwan 3
AU - Australia 2
DE - Germania 2
IN - India 2
NO - Norvegia 2
PL - Polonia 2
UA - Ucraina 2
BR - Brasile 1
CI - Costa d'Avorio 1
GB - Regno Unito 1
HK - Hong Kong 1
LK - Sri Lanka 1
TH - Thailandia 1
Totale 561
Città #
Santa Clara 49
Ann Arbor 40
Chandler 37
Fairfield 34
Singapore 22
Beijing 19
Dublin 17
Houston 15
Ashburn 14
Seattle 14
Wilmington 13
Shanghai 10
Ottawa 9
Helsinki 8
Dudelange 6
Jakarta 6
Turin 6
Cambridge 5
Columbus 5
Medford 5
Woodbridge 5
Dong Ket 4
Guangzhou 4
Nyköping 4
Pisa 4
Princeton 4
Brussels 3
Hangzhou 3
Ladispoli 3
Redwood City 3
San Diego 3
Torino 3
Villeurbanne 3
Washington 3
Boston 2
Chennai 2
Dearborn 2
Hanoi 2
Milan 2
Naples 2
Rome 2
Solna 2
Taichung 2
Warsaw 2
Abidjan 1
Bergen 1
Boardman 1
Chicago 1
Collegno 1
Falkenstein 1
Falls Church 1
Fremont 1
Göteborg 1
Hebi 1
Hong Kong 1
Lappeenranta 1
Mountain View 1
Nanjing 1
Norwalk 1
Nottingham 1
Phoenix 1
Ragama 1
San Antonio 1
Seoul 1
Songpa-gu 1
São Paulo 1
Taipei 1
Upper Marlboro 1
Vercelli 1
Vernante 1
Verona 1
Xian 1
Totale 431
Nome #
Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use 131
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma 127
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 117
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 76
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 49
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma 45
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study 37
Totale 582
Categoria #
all - tutte 2.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 5 3 2 2 5 2 3
2020/202182 5 0 3 7 2 4 12 2 12 9 13 13
2021/202298 4 7 5 5 5 3 13 14 7 5 13 17
2022/202399 10 8 3 6 9 27 10 9 7 1 4 5
2023/202465 4 9 11 5 8 6 2 4 0 2 8 6
2024/2025147 3 31 19 17 52 25 0 0 0 0 0 0
Totale 582